Good MorningEquity markets were able to claw their way higher on Wednesday despite a hot read on inflation. The August CPI came in hotter than expected at the headline and core levels due to the rise of oil prices and threatens to push the Fed into another interest rate hike. The S&P 500 moved up less than 0.25% on the news, but the fact gains were made shows the market still does not believe inflation remains a problem.
The market seems to be heading into a bull trap. The S&P 500 is in rally mode despite the rising chance for additional interest rate hikes, and it is seriously mispricing the odds. As it is, the market has yet to price in another hike, and there could be more than 1 on the way. The price of WTI is up another 2.5% so far in September, the cause of hot inflation, and it is likely to continue rising. The next FOMC policy announcement is 1 week away and poses a significant threat to bullish traders. Featured: Wall Street Insider Makes Prediction about Hot A.I. Stock (Chaikin Analytics) 
|
Markets | | |
Are you a REIT investor looking for diversification in your passive income streams? REITs are terrific vehicles for gaining exposure to the real estate market without going through the hassle of purchasing property. They're also imperfect assets with certain risks. A REIT alternative can mitigate ... Read the Full Story |
|
From Our PartnersIdentify the best stocks, monitor your portfolio, and keep track of the market with MarketBeat All Access. Try it free for 30 days. | | | | Start Your 30 Day Free Trial |
|
Stocks | | |
With Tesla Inc (NASDAQ: TSLA) shares having already rallied close to 200% this year, many investors will understandably be wary about chasing the bid. It’s always nice to feel like you’re getting shares at a discount whenever you decide to buy, but unless you’re on... Read the Full Story |
|
Markets | | |
Kroger (NYSE: KR) is no exciting stock, but that is the point. Kroger isn’t an exciting stock, but it is a blue-chip player in consumer staples; it has solid revenue and earnings, sustainable cash flow, and pays a healthy dividend. To put its non-exciting quality into better perspective, Kro... Read the Full Story |
|
From Our PartnersAre you searching for a lucrative investment opportunity in today's unpredictable market? We have the perfect solution for you: the alternative energy sector, promising an incredible 15x return on investment.
By clicking link you are subscribing to The Darwin Investor Network and may receive up to 2 additional free bonus subscriptions. Unsubscribing is easy. Full disclosures found here.
| | Click here to access our report |
|
Markets | | | Asian shares advanced Friday, with solid gains for Chinese markets after the central bank eased the reserve requirements for banks to encourage more lending and prop up the slowing economy.Hong Kong's Hang Seng surged 1.3% to 18,280.11 and the Shanghai Composite index was up 0.4%, at 3,138.94. Late ... Read the Full Story |
|
Markets | | |
Snacks and cleaning supplies aren’t the only thing on sale at Dollar General Corporation (NYSE:DG).
Last week, shares of the discount retailer fell to their lowest level since May 2019 following a dreadful second quarter earnings report. Like a bottle of generic bleach, the move erased all ... Read the Full Story |
|
From Our PartnersMarc Lichtenfeld, Author of Get Rich with Dividends, is giving away his Ultimate Dividend Package, Including Details on His #1 Dividend Stock... the Safest 8% Dividend in the World... the Top Three "Extreme Dividend" Stocks... and Much, Much More. | | | | For Free. |
|
Markets | | |
Based out of Canada, Enbridge Inc. (NYSE: ENB) operates the world's longest crude oil and liquids transportation system, totaling 17,809 miles of active pipeline. While it also has core businesses in the natural gas pipelines, gas utilities and storage and renewable energy segment, it still collec... Read the Full Story |
|
Markets | | | The British economy shrank by 0.5% in July amid a series of strikes, particularly by doctors at the start of their careers, and unseasonably wet weather, official figures showed Wednesday.The Office for National Statistics said the strikes by so-called junior doctors weighed on health sector activit... Read the Full Story |
|
Markets | | | A record of more than one in five young Chinese are out of work, their career ambitions derailed by a depressed job market as the economy struggles to regain momentum after its long bout with COVID-19 Read the Full Story |
|
Markets | | | When the unexpected happens — whether fire, hail, or human error — renters insurance can provide much-needed stability. But many choose not to purchase coverage, including in places most frequently and hardest hit by natural disasters, new research shows.Linda Klamm, who works as an attorney for ins... Read the Full Story |
|
Markets | | | Shares of TKO Group, the new company that houses WWE and UFC, opened at $102 per share in their first day of trading on the New York Stock Exchange on Tuesday.Endeavor Group Holdings Inc. has closed its previously announced deal with World Wrestling Entertainment Inc. The pairing of WWE with the com... Read the Full Story |
|
Thursday's Early Bird Stock Of The Day Celularity Inc., a clinical-stage biotechnology company, develops off-the-shelf placental-derived allogeneic cell therapies for the treatment of cancer, immune, and infectious diseases. It operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. The company's lead therapeutic programs include CYCART-19, an allogeneic CAR-T cell for the treatment of non-Hodkin's lymphoma (NHL) and mantle cell lymphoma (MCL); CYNK-001, an allogeneic unmodified natural killer cell that is in Phase I/II clinical trial for the treatment of acute myeloid leukemia (AML); and APPL-001, a genetically modified placental-derived mesenchymal-like adherent stromal cell for the treatment of Crohn's disease. It is also developing CYCART-201 for the treatment of NHL and MCL, and human epidermal growth factor receptor 2 positive cancers; CYNK-301, a next generation chimeric antigen receptor-natural killer (CAR-NK) for treating relapse refractory AML; CYNK-302, a CAR-NK to treat non-small cell lung cancer; and pExo-001, a human postpartum placenta derived exosome product for the treatment of osteoarthritis. It also produces, sells, and licenses products that are used in surgical and wound care markets, such as Biovance, Biovance 3L, Interfyl, and Centaflex; and collects and stores stem cells from umbilical cords and placentas under the LifebankUSA brand. The company has licensing agreement with Sorrento Therapeutics, Inc. for the development and commercialization of licensed CD19 CAR-T products; and research collaboration services agreement with Regeneron Pharmaceuticals, Inc. to support the research of allogeneic cell therapy candidates. The company was founded in 1998 and is based in Florham Park, New Jersey. | | View Today's Stock Pick |
|
